Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
C

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymphoma

By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
31 views
August 15, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi
Hodgkin Lymphoma
20:26
2018 Pan Pacific Lymphoma Conference

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lympho…

Feat. R. Hoppe
10:00
2018 Pan Pacific Lymphoma Conference

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

Feat. C. Moskowitz
15:48
2018 Pan Pacific Lymphoma Conference

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymp…

Feat. C. Moskowitz
21:11
2018 Pan Pacific Lymphoma Conference

Use of Total Metabolic Tumor Volume in PET Scans

Feat. N. Hansen
06:45
2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma: First Relapse Options

Feat. B. Pro
16:04
2018 Pan Pacific Lymphoma Conference

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

Feat. B. Pro
20:54
2018 Pan Pacific Lymphoma Conference

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

Feat. S. Ansell
14:48
2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

Feat. A. Engert